2027 Medical Patients Provider 
Minnesota Academy of Family Physicians
MARCH 13, 2025
Last week, the Minnesota Academy of Family Physicians (MAFP) was actively engaged in multiple discussions on health care policy, including Medical Assistance rate reimbursement, coverage for the Psychiatric Collaborative Care Model and broader reforms to patient-centered care. Highlights follow.
The Medical Futurist
MAY 18, 2025
Assisting surgeries, disinfecting rooms, dispensing medication, keeping company: believe it or not these are the tasks medical robots will soon undertake in hospitals, pharmacies, or your nearest doctor’s office. Instead of a human, however, they used a mannequin designed for medical training.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
California Academy of Family Physicians (CAFP)
MAY 14, 2025
However, for individuals who do not qualify for federal Medicaid funding—such as most undocumented immigrants—the federal government does not provide matching funds, even when those individuals meet income eligibility requirements. GLP-1 Drugs for Weight Loss : Ends coverage for GLP-1 medications used for weight loss starting January 1, 2026.
FDA Law Blog
MAY 13, 2024
Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). FDA defines real-world data ( RWD ) as “data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources.” By Jeffrey N.
FDA Law Blog
OCTOBER 6, 2023
The end of enforcement discretion The PR proposes to phase out LDT “enforcement discretion” over a period of four years, after which most LDTs will be subject to all applicable medical device regulatory requirements. It does not extend to tests for which FDA has historically not exercised enforcement discretion (e.g., 150,000).”
FDA Law Blog
SEPTEMBER 20, 2021
When FDA published the fiscal years (FY) 2023-2027 goals letter at the end of August, making known their commitments and planned initiatives for the coming years, we were both excited by many of the announcements, while recognizing the real success will come from how the Agency implements them.
FDA Law Blog
OCTOBER 24, 2022
These data are routinely collected from a variety of sources, such as electronic health records, providing information on health and healthcare in actual patients, rather than in the controlled environment of a clinical trial. There will be two submission deadlines per year on March 31 and September 30, through March 31, 2027.
Expert insights. Personalized for you.
52 
Let's personalize your content